Chapter Activities 

Health System and COVID-19 - ISPOR Poland Chapter Perspectives

In Poland there are 1,862 total cases, out of each there are 1,833 active cases, 7 people recovered [1]. Twenty-two patients died, which gives a mortality at the level of 1,18%. 

Just after receiving confirmation about an epidemic outbreak in China, the Warsaw Chopin Airport made special surveys for passengers arriving from China coupled with temperature measure. As of 29 February 2020, the National Institute of Public Health – National Institute of Hygiene (firstly supported by the Berlin hospital Charité) started to carry out testing. Now many state laboratories carry out testing of suspected cases based on PCR. Their capacity is growing. In addition to laboratory testing, home quarantining and epidemiological surveillance (supported by the police) has been introduced. 

The first case of a laboratory confirmed COVID-19 infection in Poland was that of a man who traveled from Germany, he was hospitalized in south west of Poland, according to an official announcement on 4 March 2020 [2]. The local transmission phase of coronavirus in Poland was declared to the World Health Organization on 10 March [3]. The first death from coronavirus disease in Poland was that of a 56-year-old woman on 12 March [4]. 

A new special law to manage a possible epidemic of COVID-19 in Poland through administrative, budgetary and epidemiological measures passed through the Polish Parliament with 400 votes out of 418 in favor of the regulation [5].

According to the new law, on 10 March, all mass events were cancelled (for more than 1000 participants outside buildings, and 500 or more participants in inner space). All cultural institutions, such as cinemas, theatres, museums, had their activities suspended from 12 March 2020. Similarly, all schools in Poland were closed starting 12 March until Easter holiday. Universities and schools were required to carry out online classes with their students. Universities cancelled classes for the same period, while keeping research in a remote setting and part of administrative staff [6].

An official epidemic was declared in Poland on 20 March 2020 by the prime minister, Mateusz Morawiecki. Border control was re-introduced, all flights cancelled.

On 24 March, Poland's government announced further restrictions on people leaving their homes and on public gatherings to further limit the spread of COVID-19 infections. The new limits constrained gatherings by default to a maximum of two people (with an exception for families) with an exception for religious gatherings, in which five participants were allowed to gather. Non-essential travel was prohibited, with the exception of travelling to work or home. Everyday activities qualifying as "necessary" included shopping, buying medicines, visiting doctors, walking dogs, jogging, cycling and walking, provided that no more than two people participate and contact with others was avoided. The restrictions were initially defined for the period from 25 March to 11 April inclusive.

Healthcare sector is in the process of preparing for the wider spread of epidemic. More cases are expected.

References
https://www.covidvisualizer.com/?fbclid=IwAR3VJB69t7h1eEgHoIeMj4vFEjeBpmFUi_D8U33n5837vYEqunaNe-svtuE Accessed 29.03.2020

Poland Reports First Coronavirus Case - Health Minister 4 March 2020. Accessed 4.03.2020

Coronavirus disease 2019 (COVID-19) – Situation Report – 49 (PDF). WHO. 9 March 2020. Accessed 29.03.2020

Minister @SzumowskiLukasz  #MZ: Mamy pierwszy śmiertelny przypadek wywołany przez #koronawirus. Pacjentka w wieku 56 lat miała poważne problemy zdrowotne przed zakażeniem. (in Polish) Twitter. 12 March 2020

Rządowy projekt ustawy o szczególnych rozwiązaniach związanych z zapobieganiem, przeciwdziałaniem i zwalczaniem COVID-19, innych chorób zakaźnych oraz wywołanych nimi sytuacji kryzysowych  Sejm (in Polish). 3 March 2020

Szkoły pozostaną zamknięte do Wielkanocy. Harmonogram roku szkolnego bez zmian" TVN24 (in Polish). Accessed 21.03.2020

ISPOR Warsaw 2019: 27-28 March; Warsaw, Poland

Theme: Navigating Joint HTA, Procurement and Fair Pricing-Evidence-Based Insights and Practical Recommendations

Why Attend?

Registration Fees

Venue and Hotel Information


16th International Conference of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter); 29-30 November 2018; Warsaw, Poland

HTA Development - Challenges, Practical Solutions, and Expected Benefits

The annual conference focused on discussing drug policy in Poland and the future of HTA in the light of new regulations. Other presented topics included: current trends in HEOR, e-health, and reimbursement policy, which were delivered by regional and international panel of experts in healthcare. The conference was opened by Prof Lukasz Szumowski, Minister of Health in the Polish Ministry of Health.

Conference Schedule and Registration 

Program (in Polish)


XV International Conference of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter); 30 November - 1 December 2017; Warsaw, Poland

Drug Pricing in Europe - Fair, Uniform or Both?

The Polish Pharmacoeconomics Society (ISPOR Poland Chapter) held the XV Annual International Conference on 30 November -1 December 2017 in the Hotel Airport Okecie, Warsaw, Poland.

ISPOR Poland Chapter organized the 15th International Conference on 30 November-1 December 2017 in Warsaw, Poland. Dr Maciej Niewada, President of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter), Dr Joanna Lis, Past President; Prof Marcin Czech, Under Secretary of State at the Polish Ministry of Health ), delivered a warm welcome to the attendees of the conference.

The main topic of the conference was, "Drug Pricing in Europe – Fair, Uniform or Both?," was presented by Dr Zoltan Kalo (Hungary) on Thursday, November 30.

A panel discussion on rational medicinal policy in Central and Eastern Europe countries followed the topic and has been moderated by Dr Maciej Niewada. Many experts from European countries participated as speakers at the event, including Dr Jiri Samek (Czech Republic), Prof John Yfantopoulos (Greece), and Prof Tomas Tesar (Slovakia).  

Afternoon session was devoted to the situation of HTA in Poland with presentations of the Polish Agency for Health Technology Assessment representatives.

The second day of the conference, Friday, 1 December, was dedicated to a session on medical devices, followed by session of RWE, Polish EQ-5D-5L valuation study, and HTA in oncology and in hospital setting.

Afternoon session involved student presentations of original studies. 


XIV International Conference of the Polish Pharmacoeconomics Society

(ISPOR Poland Chapter), December 1-2, 2016, Warsaw, Poland

Effective Investment in a Coordinated Health Care

The conference focused on the topic of investing in coordinated care and featured presentations by regional and international experts. The Polish Deputy Minister of Health, Dr. Krzysztof Łanda spoke about the new possibilities for reimbursement of medical devices, amendments in reimbursement act and changes planned in health policies in Poland. ISPOR President, Prof. Lou Garrison, delivered a presentation on “The Second U.S. Panel Report on CEA: Key Findings and Implications for HTA,” and Prof. Ben van Hout presented on good economic practice, sensitivity analysis, and medical devices. The ISPOR CEE Network Chair, Vlad Zah and President of ISPOR Greece Chapter, Prof. John Yfantopoulos participated in a session discussing the potential support of e-health system for reimbursement decision-making. The conference was attended by more than 180 participants and was preceded by series of workshops on health technology assessment, risk-sharing schemes, new HTA guidelines and other hot topics related to HTA in the region. 

The Second U.S. Panel Report on CEA: Key Findings and Implications for HTA Presentation


Patients Registries: The Role of Health System, New Trends and Hopes for Polish Patients,

March 19, 2015, Hotel Radisson Blu Sobieski, Warsaw, Poland

Scientific conference organized under the auspices of the Polish Pharmacoeconomic Society (ISPOR Poland Chapter) and the Journal of Health Policy & Outcomes Research (JHPOR)

Patients registries are collected data, based on a standardized description of the patient and identification of methods used for the procedure, in order to determine the specific effects in the study population. Measured effects can affect different areas: health outcomes, therapeutics or medicine policy, and even the sociology of patients’ behavior.  May patients records improve the functioning of health care? Can we get more benefits from patient registries in Poland? How do other countries use this knowledge? These and other questions will be addressed during the conference by international experts and representatives of the Polish health institutions. The conference will end with the postulate of the "seven milestones", presenting recommendations for the role of patient registries functioning in Poland. For questions, please contact: konferencja@jhpor.com 



Therapeutic and Diagnostic Device Outcomes Research - Translated into Polish!

The translation has been completed by regional experts and members of ISPOR Poland Chapter

Activity

 “Therapeutic and Diagnostic Device Outcomes Research is the first such comprehensive publication available in Polish language, which as a whole deals with the subject of clinical effectiveness assessment and economic efficiency of products used in medical diagnosis and treatment. It provides necessary information for the Polish medical decision makers, payers, health care experts, analysts, clinicians and patients. It is a very important element of Pharmacoeconomic education. We have dealt so far mainly with drugs and now we have a ‘bible’ for medical devices. I am sure that this translation will be welcomed by Polish readers with a high interest and attention.” - Joanna Lis, MSc, PhD, President, ISPOR Poland Chapter.


Those interested in obtaining the Polish translation of the book, please contact: biuro@farmakoekonomika.pl or joanna@fraktal.com.pl.

For more information on all ISPOR books, visit: http://www.ispor.org/publications/BooksIndex.asp

 

 


Contact Information

Poland Regional Chapter Office

The Polish Pharmacoeconomics Society
ul. Śliska 3 lok. 55
00-127 Warsaw, Poland 

Chapter Leadership

 

PresidentMaciej Niewada, MD
Past-PresidentJoanna Lis, MSc, PhD
SecretaryMarcin Czech, MD
DirectorWitold Owczarek, MD

More Details

image96
Fig. 1 COVID-19 cases in Poland
Source: Polish Ministry of Health
image96

Panel discussion during the 15th International Conference in Warsaw,Poland on 30 November-1 December 2017

image97

Maciej Niewada (Chapter President), Joanna Lis (Chapter Past-President), and Tomasz Hermanowski (Congress Program Committee Co-Chair) at ISPOR European Congress, Vienna 2016

image98

Members of ISPOR Poland Chapter at ISPOR 16th European Congress, Dublin

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×